Clinical trial Recruiting at 1 site Interventional Ages 18 and up

FARES vs. traction-countertraction for acute anterior shoulder dislocation

Official title: The FARES Versus Traction-Countertraction Technique for Acute Anterior Shoulder Dislocation: A Randomized Controlled Trial

Run by University of Medicine and Pharmacy at Ho Chi Minh City · NCT07757594 · Data updated 2026-11-12

This trial tests whether the FARES technique can reduce an acute anterior shoulder dislocation faster and with less pain than the traditional traction-countertraction method in adults.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City
Academic / other
Locations1 site (Ho Chi Minh City, Ho Chi Minh City)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedSeptember 15, 2026
Trial IDNCT07757594 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with acute anterior shoulder dislocation confirmed by radiographs, within 24 hours of injury, and with either a simple dislocation or a greater tuberosity fracture only, who are conscious, cooperative, and provide informed consent.

Probably not a fit

Patients with polytrauma, neurovascular deficits, contraindications to reduction, prior shoulder surgery, or other upper-extremity injuries may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two closed reduction methods for acute anterior shoulder dislocation in adults. Participants are assigned to receive either the FARES technique or the traction-countertraction technique. Outcomes include reduction success, pain during the procedure, time to reduction, and procedure-related complications. The study aims to provide evidence on which method offers faster, safer, and more comfortable reduction in emergency care settings. Conducted at a single center in Ho Chi Minh City, it seeks to inform emergency department practice for this common orthopedic emergency.

Why it matters

Potential benefit: If successful, the FARES technique could offer faster reductions with less pain for patients experiencing acute anterior shoulder dislocation.

How similar studies have gone: Previous work has explored FARES in this setting, but direct randomized comparisons to traction-countertraction are limited, making this a relatively novel evaluation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.
* Conscious and cooperative patients.
* Anterior shoulder dislocation confirmed by shoulder radiographs (anteroposterior view and Y-view).
* Time from injury to reduction \<24 hours.
* Simple anterior shoulder dislocation or anterior shoulder dislocation associated with greater tuberosity fracture only.
* Patient agrees to participate in the study and provides informed consent.

Exclusion Criteria:

* Other injuries of the same upper extremity.
* Neurovascular deficits before reduction.
* Polytrauma, hemodynamic instability, or medical conditions contraindicating immediate reduction.
* Previous surgery of the affected shoulder.

Where it's running

  • Hospital for Traumatology and Orthopaedics
    Ho Chi Minh City, Ho Chi Minh City, Vietnam
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.